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Kikuchi disease (also known as histiocytic necrotizing lymphadenitis [HNL], Kikuchi-Fujimoto disease [KFD]) was first reported in young Japanese females in 1972. It 
is a self-limited disorder of unknown etiology, characterized by 
focal painful lymphadenitis, fever, malaise, and weight loss [1]. 
Kikuchi disease affects a wide age range of patients (2-75 years) 
but typically affects young adults (mean age, 20-30 years) [2]. 
In general, a female preponderance has been reported with a 
female to male ratio of 4:1 [3]. The condition has been reported 
predominantly in the Asian population and occurs sporadically 
outside Asia [1].
Kikuchi’s disease typically is self-limited, usually resolving 
within 1-4 months. A low recurrence rate of 3% to 4% has 
been reported [3]. Diagnosis of KFD is based on characteristic 
histopathologic features on excision biopsy of affected lymph 
nodes. The onset of Kikuchi’s disease is usually acute or subacute 
with fever and regional lymphadenopathy (mostly cervical). 
Extranodal involvement in Kikuchi’s disease is rare and has been 
documented in skin, bone marrow, myocardium, and central 
nervous system [3]. We report a case of Kikuchi disease with 
multisystem involvement in a 14-year-old Chinese boy.
CASE REPORT
The child was admitted to our hospital with 3 weeks of fever 
(daily spikes >39°C), intermittent frontal headaches, rash, weight 
loss (2 kg), oral ulcers (for 1 week), and feeling tired. There was 
no history of any recent overseas travel or contact with any sick 
person. Clinical examination revealed a febrile child with multiple 
left cervical lymphadenopathy (1-2 cm in size, non-tender), 
hepatomegaly (2 cm), and erythematous maculopapular rash on 
trunk and limbs. Rest of the examination was unremarkable.
The child was extensively investigated for fever of unknown 
origin and empirically treated with intravenous antibiotics 
(ceftriaxone and clindamycin). During his stay, we also requested 
input from our rheumatology, infectious disease, and hematology 
colleagues. Investigations including blood, stool, urine cultures, 
rickettsia, toxoplasmosis, Epstein-Barr virus, cytomegalovirus 
(CMV), salmonella serology, Herpes simplex virus (HSV) 
polymerase chain reaction (PCR), tuberculosis (TB) (T-spot test), 
antinuclear antibodies (ANA), and anti-dsDNA were negative. 
He had raised ASOT (800 units), lactate dehydrogenase (LDH) 
524 (170-283 U/L), erythrocyte sedimentation rate (ESR) 
(170 mm/h), and C-reactive protein (CRP) (46 mg/l). Bone 
marrow showed no evidence of malignancy.
Child continued to spike fever for 9 days during inpatient stay 
in spite of being on above antibiotics (ceftriaxone for 9 days and 
clindamycin for 6 days). Finally, cervical lymph node excision 
biopsy was done (day 9 of inpatient stay) for suspicion of 
Kikuchi’s disease which confirmed the Kikuchi’s lymphadenitis 
(Figs. 1 and 2). The child was started on oral prednisolone 
and discharged after 12 days of inpatient stay (day 3 of oral 
prednisolone at 1 mg/kg/day, to be continued for another week) 
when symptoms improved and afebrile. He was given a follow-up 
clinic appointment in a week.
The child got readmitted 4 days post hospital discharge with 
generalized seizures requiring anticonvulsants (intravenous 
lorazepam and phenytoin) and elective intubation and ventilation. 
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Urgent computed tomography brain scan was normal. The 
child was empirically treated for meningitis/encephalitis with 
intravenous ceftriaxone, acyclovir, and ciprofloxacin (to cover 
for atypical organisms). LP was suggestive of aseptic meningitis 
(clear, colorless, white blood cell; 9/mm3, red blood cells: 12/mm3, 
protein: 0.34g/L, glucose: 3.3 mmol/L). Cerebrospinal fluid (CSF) 
studies including latex (bacterial antigen) agglutination, Gram-stain 
and culture, HSV/enterovirus PCR, cryptococcus antigen, acid-fast 
bacilli smear and culture, and CSF globulin were negative.
Liver function tests (LFT) were deranged (total bilirubin: 
50 umol/L, direct bilirubin: 36 umol/L, albumin: 24 g/L, 
ALT: 230 U/L, aspartate aminotransferase: 112 U/L, gamma-
glutamyl transferase: 1155 U/L, LDH: 1596 U/L, CRP: 19 mg/L, 
ESR: 40 mm/h, serum ferritin 9174 ug/l (significantly raised), 
serum triglycerides 0.8 mmol/L, lupus anticoagulant not 
demonstrated, complement levels were mildly raised (C3 1.45, 
C4 0.48 G/L), anti-N-methyl-D-aspartate receptor antibodies 
(CSF/blood) not detected, DCT-positive anemia (hemoglobin: 
9.1 g/dl). Skin biopsy of rash showed necrotic epidermis with 
features of interface dermatitis (Fig. 3). Magnetic resonance 
imaging/magnetic resonance angiogram brain was normal.
The child was diagnosed with Kikuchi’s disease with 
multisystem involvement (aseptic meningitis, raised liver 
transaminases, DCT-positive anemia, and interface dermatitis) 
and treated with intravenous methylprednisolone (3 days) and 
antibiotics, followed by oral steroids and antibiotics on discharge.
The child has remained well and LFTs and anemia improved 
on subsequent clinic visits. He will continue to be monitored 
closely for the next few years for any evolving symptoms of 
systemic lupus erythematosus (SLE) or any other autoimmune 
disorder.
DISCUSSION
KFD patients can suffer classic symptoms, which include fever, 
fatigue, and cervical lymph node enlargement and can also have 
unusual presentation, such as axillary and inguinal lymph node 
enlargement, skin rash, arthralgia, splenomegaly, and aseptic 
meningitis. KFD can even be complicated with fatal outcomes 
such as disseminated intravascular coagulopathy and pulmonary 
hemorrhage [4].
The etiology of Kikuchi’s disease is unknown, although a 
viral, genetic, and an autoimmune hypothesis has been proposed. 
Several infectious agents have been implicated, including Epstein-
Barr virus, human herpesvirus 6, human immunodeficiency 
virus, HTLV 1, HSV, hepatitis B, dengue virus, parvovirus B 19, 
Yersinia enterocolitica, Bartonella, Brucella, and toxoplasma 
organisms [3].
Sierra et al. [5] reported a case of a 14-year-old boy 
presenting with severe systemic manifestations (fever up to 
39.8°C for 1 week, malaise, odynophagia, arthralgia, myalgia, 
abdominal pain, and pruritic skin eruption, several multiple 
peripheral cervical, axillary, and inguinal adenopathies, 
hepatosplenomegaly and erythematous, flat-topped papules on 
the face, back, and extremities) diagnosed with Kikuchi disease 
(on lymph node biopsy) and treated empirically with corticoids 
(intravenous methylprednisolone) and antituberculosis drugs 
(Isoniazid, rifampicin, pyrazinamide) while awaiting definitive 
Figure 1: H and E stained section (×20) of cervical lymph node 
showing paracortical expansion with residual follicles
Figure 3: H and E section (×200) of skin lesion showing interface 
inflammation with epidermal lymphocytic exocytosis and focal 
epidermal necrosis
Figure 2: H and E stained section (×400) showing paracortical areas 
containing activated lymphocytes, immunoblasts, crescent-shaped 
histiocytes, foci of karyorrhectic debris, and absence of neutrophils
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microbiologic test results, who developed transient fulminant 
hepatic failure in response antituberculous drugs.
Paradela et al. [6] reported a case of a 17-year-old woman 
with KFD (diagnosed on a lymph node biopsy), who a month 
later developed an erythematous edematous rash on her upper 
body, with skin biopsy showing interface dermatitis. After 
8 months, ANA at titer of 1/320, anti-DNA-ds antibodies, and 
marked decrease of complement levels were detected. During 
the following 2 years, she developed diagnostic criteria for SLE 
(arthralgias, pleuritis, aseptic meningitis, hemolytic anemia, 
and lupus nephritis). This histopathological finding of interface 
dermatitis not previously considered significant might be a 
marker of evolution into SLE.
Khishfe et al. [7] presented a case report of a patient who 
presented to the emergency department with signs and symptoms 
suggestive of aseptic meningitis and ultimately diagnosed with 
Kikuchi disease. The inclusion of Kikuchi disease in the differential 
diagnosis for meningitis may help establish a diagnosis in patients 
also presenting with regional lymphadenopathy.
Clinical differential diagnosis for Kikuchi disease includes 
infectious mononucleosis, bacterial lymphadenitis, cat scratch 
disease, mycobacterium TB, CMV disease, toxoplasmosis, SLE, 
malignancy, and Kawasaki disease [1].
Diagnosis of Kikuchi’s disease is confirmed by lymph node 
biopsy showing histiocytic necrotizing lymphadenitis. SLE 
presents the most challenging disorder from which it has to be 
differentiated. SLE lymphadenitis demonstrates aggregates of 
degenerated nuclear debris, degenerated nuclear material in 
walls of blood vessels, prominent reactive hyperplasia, abundant 
plasma cells, and capsular or pericapsular inflammation. 
Features that favour Kikuchi’s disease include predominance of 
CD8 + cells, absence of neutrophils, and a relative paucity of 
plasma cells [3].
Corticosteroid therapy may speed up recovery in patients 
with Kikuchi disease [1]. Patients with classic symptoms respond 
to NSAIDs or steroid, and those with severe symptoms usually 
respond to steroids. Immunosuppressants have been recommended 
for the complicated case to prevent fatal outcome [4]. Hyun et al. 
reported a case of a KD patient who was unresponsive to NSAIDs 
and steroids, and experienced symptom resolution after treatment 
with hydroxychloroquine (HC). This leads to the consideration 
about the use of HC for the treatment of KFD patients who have 
persistent symptoms, treated by NSAIDs and steroids [4].
Association between Kikuchi’s disease and SLE has been 
reported, with some patients of Kikuchi’s disease developing a 
full-blown SLE. Kikuchi’s disease can also precede or coincide 
with the diagnosis of SLE, and SLE should always be excluded 
in patients presenting with necrotizing lymphadenitis. It is 
recommended to perform ANA screening at the time of diagnosis, 
and the patients with Kikuchi’s disease should also have a 
follow-up evaluation for SLE [3]. The prognosis for Kikuchi is 
generally optimistic; however, a concurrent autoimmune disease 
or the risk of developing an autoimmune disease needs careful 
monitoring [8].
CONCLUSION
Our case report highlights the fact that although Kikuchi disease 
usually presents with fever and lymphadenopathy, it may also 
present with multisystem involvement. Awareness of this benign 
condition among clinicians and pathologists will help with early 
diagnosis and avoid expensive, extensive, and unnecessary 
investigations in a young child presenting with fever and 
lymphadenopathy.
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